LFST Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
LifeStance Health Group Inc (LFST) is a good buy for a beginner investor with a long-term focus and $50,000-$100,000 available for investment. The company's strong analyst support, positive growth outlook, and favorable technical indicators outweigh the insider selling and recent pre-market price dip. The SwingMax signal further supports a buy decision.
The MACD is positive and expanding, indicating bullish momentum. RSI is neutral at 59.326, suggesting no overbought or oversold conditions. Moving averages are converging, and the stock is trading near its resistance level (R1: 6.681). Overall, the technical indicators show a moderately positive trend.
Analysts have consistently raised price targets, with the latest targets ranging from $9 to $12, citing strong growth, productivity improvements, and favorable reimbursement rates.
SwingMax signal from 2026-03-19 indicates a buy opportunity with a 3.11% price increase since the signal.
Revenue growth of 17.43% YoY in Q4 2025 highlights the company's ability to expand its business.
Insiders have significantly increased selling activity, with a 16832.26% rise in the last month.
Net income and EPS have dropped significantly YoY, indicating profitability challenges.
Pre-market price is down by 0.75%, reflecting short-term bearish sentiment.
In Q4 2025, revenue increased by 17.43% YoY to $382.2M, showcasing strong growth. However, net income dropped by -264.06% YoY to $11.67M, and EPS declined by -250.00% YoY to $0.03, reflecting profitability challenges. Gross margin remained stable at 100%.
Analysts are optimistic, with multiple firms raising price targets and maintaining Buy/Overweight ratings. The consensus highlights strong growth prospects, improved clinician productivity, and favorable reimbursement environments as key drivers for future performance.
